Bridging Therapies—Ex Vivo Liver Xenoperfusion and the Role of Machine Perfusion: An Update
Xenotransplantation · 2025-01 · 32 (1)
DOI: 10.1111/xen.70011 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Xenotransplantation, online erschienen am 18.01.2025. Verfasst von Zoltan Czigany und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General, Visceral, and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Transplantation, Heterologous, Liver Transplantation, Perfusion, Liver. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 80 Literaturangaben.
Abstract (Originalsprache)
Advancements in xenotransplantation intersecting with modern machine perfusion technology offer promising solutions to patients with liver failure providing a valuable bridge to transplantation and extending graft viability beyond current limitations. Patients facing acute or acute chronic liver failure, post‐hepatectomy liver failure, or fulminant hepatic failure often require urgent liver transplants which are severely limited by organ shortage, emphasizing the importance of effective bridging approaches. Machine perfusion is now increasingly used to test and use genetically engineered porcine livers in translational studies, addressing the limitations and costs of non‐human primate models. Current reports about artificial and bioartificial liver support combined with xenografts showcase the potential in ex vivo xenogeneic perfusion. Breakthroughs, such as the perfusion of genetically modified porcine liver with FDA‐approved machine perfusion systems connected to human blood circulation, underscore the interest and potential feasibility of a “liver dialysis” bridge to allotransplantation or recovery. This review provides an overview of the past and current research in the field of ex vivo pig liver xenoperfusion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General, Visceral, and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany.
- Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Division of Transplant Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Raphael P H Meier
Zitieren
APA
Czigany, Z., Shirini, K., Putri, A. J., Longchamp, A. E., Bhusal, S., Kamberi, S., & Meier, R. P. H. (2025). Bridging Therapies—Ex Vivo Liver Xenoperfusion and the Role of Machine Perfusion: An Update. Xenotransplantation, 32(1). https://doi.org/10.1111/xen.70011
Vancouver
Czigany Z, Shirini K, Putri AJ, Longchamp AE, Bhusal S, Kamberi S, et al. Bridging Therapies—Ex Vivo Liver Xenoperfusion and the Role of Machine Perfusion: An Update. Xenotransplantation. 2025;32(1). doi:10.1111/xen.70011
BibTeX
@article{Czigany2025,
author = {Czigany, Zoltan and Shirini, Kasra and Putri, Aghnia J and Longchamp, Alban E and Bhusal, Subarna and Kamberi, Shani and Meier, Raphael P H},
title = {Bridging Therapies—Ex Vivo Liver Xenoperfusion and the Role of Machine Perfusion: An Update},
journal = {Xenotransplantation},
year = {2025},
volume = {32},
number = {1},
doi = {10.1111/xen.70011}
}
EUVIMED